Compare
Medtronic plc vs Conmed Corp vs TransMedics Group, Inc.
| Latest fiscal year | Medtronic plc MDT | Conmed Corp CNMD | TransMedics Group, Inc. TMDX |
|---|---|---|---|
| Year ended | 2026-04-24 | 2025-12-31 | 2025-12-31 |
| Revenue | $36.36B | $1.37B | $605.49M |
| Revenue growth (YoY) | +8.4% | +5.2% | +37.1% |
| Gross margin | 65.0% (computed) | 54.6% | 59.9% |
| Operating margin | 17.8% | 7.5% | 17.9% |
| Net margin | 13.2% | 3.4% | 31.4% |
| Net income | $4.80B | $47.05M | $190.29M |
| EPS (Diluted) | $3.73 | $1.51 | $4.87 |
| Operating cash flow | $7.33B | $170.69M | $192.84M |
| Free cash flow | $5.43B | $150.88M | $133.59M |
| Cash & equivalents | $1.95B | n/a | n/a |
| Total assets | $93.03B | $2.33B | $1.07B |
| Total liabilities | $42.96B | $1.29B | $595.27M |
| Shareholders' equity | $49.46B | $1.03B | $473.10M |
| Return on year-end equity | 9.7% | 4.6% | 40.2% |
| Shares outstanding | 1.28B | n/a | 34.27M |
Revenue, most recent five fiscal years
| Fiscal year | Medtronic plc | Conmed Corp | TransMedics Group, Inc. |
|---|---|---|---|
| Latest | $36.36B Ended 2026-04-24 | $1.37B Ended 2025-12-31 | $605.49M Ended 2025-12-31 |
| 1 year earlier | $33.54B Ended 2025-04-25 | $1.31B Ended 2024-12-31 | $441.54M Ended 2024-12-31 |
| 2 years earlier | $32.36B Ended 2024-04-26 | $1.24B Ended 2023-12-31 | $241.62M Ended 2023-12-31 |
| 3 years earlier | $31.23B Ended 2023-04-28 | $1.05B Ended 2022-12-31 | $93.46M Ended 2022-12-31 |
| 4 years earlier | $31.69B Ended 2022-04-29 | $1.01B Ended 2021-12-31 | $30.26M Ended 2021-12-31 |